Search Results for B-Cell Lymphoma

New Lymphoblastic Lymphoma Findings from Duke University Published

2012 MAY 24 ... 90% of lymphoblastic lymphomas arise from T cells, with the remaining 10% being B-cell-lineage derived." "Although T-cell lymphoblastic lymphoma most ... According to the authors of a study from Durham, North Carolina, "Lymphoblastic lymphoma is the second most common type of non-Hodgkin lymphoma seen in children. ...

Subject: Lymphoblastic Lymphoma

Reports from L. Cai et al Highlight Recent Research in Lymphoma

2012 MAY 25 ... "Primary bone lymphoma (PBL) represents less than 1% of all malignant lymphomas. In this study, we ...

Subject: Lymphoma

Research Findings from University of Nebraska Update Understanding of T-Cell Lymphoma

2012 MAY 23 ... hematopathologists to reproducibly diagnose aggressive PTCL is lower than for aggressive B-cell lymphomas, with a range of 72-97% for the aggressive PTCLs. Risk Stratification: ... report. "Diagnosis: The diagnosis of aggressive peripheral T-cell lymphoma (PTCL) is usually made using the WHO classification. The ability of ...

Subject: T-Cell Lymphoma

Research from King Hussein Cancer Center Has Provided New Data on Lymphoma

2012 MAY 24 ... Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables," is ...

Subject: Lymphoma

Research from Peking Union Medical College Has Provided New Information about Mantle Cell Lymphoma

2012 MAY 23 ... hydroxamic acid (SAHA) and anti-CD20 monoclonal antibody rituximab in mantle cell lymphoma have been examined both in vitro and in vivo. The combination of SAHA and ...

Subject: Mantle Cell Lymphoma

Research on Biological Inorganic Chemistry Detailed by Investigators at Children's Hospital

2012 MAY 23 ... (phen is phenanthroline) was markedly more active towards BJAB lymphoma cells than ex vivo healthy leukocytes and caused an immediate decrease in ...

Subject: Biological Inorganic Chemistry

Research on Ischemia Discussed by Investigators at University of Connecticut

2012 MAY 23 ... phospho-adenosine monophosphate-activated protein kinase (AMPK), phospho-AKT and B cell lymphoma-2 (Bcl-2) in Cav-1 KO preconditioned heart," wrote M. Das and colleagues, ...

Subject: Ischemia

Research on Lymphoma Detailed by Investigators at Weill Cornell Medical College

2012 MAY 23 ... twenty two patients were studied although the majority had low grade or mantle cell lymphoma. All had received at least two or more prior therapies. Overall, 75% achieved an ...

Subject: Lymphoma

Researchers from Oregon State University Describe Findings in Leukemia

2012 MAY 23 ... agent in a dibenzo[def,p]chrysene (DBC)-dependent model of murine T-cell lymphoblastic lymphoma." "The primary objective of the present study was to extend our ...

Subject: Leukemia

Researchers from University of Texas Publish Findings in B-Cell Lymphoma

2012 MAY 23 ... T-cell class switching and T-helper 1 response against B cell lymphoma" new findings in B-Cell Lymphoma. According to the authors of a study from Austin, Texas, "Patients with malignant ...

Subject: B-Cell Lymphoma

Researchers' Work from University of California Focuses on Non-Hodgkin Lymphoma

2012 MAY 23 ... and has withstood challenge for more than 50 years. Radioimmunotherapy for non-Hodgkin lymphoma is a more recent example of theranosis. Either of 2 anti-CD20 monoclonal ...

Subject: Non-Hodgkin Lymphoma

Studies from Department of Medicine Update Current Data on Lymphoma

2012 MAY 23 ... (RSCL), -resistant cell lines (RRCL) and primary tumour-cells derived from patients with B-cell lymphomas (N=39). Obatoclax also enhanced the activity of rituximab and had ...

Subject: Lymphoma

Studies from M. Casais and Co-Researchers Yield New Data on Sex Hormones

2012 MAY 23 ... respectively, involved in progesterone synthesis and catabolism, and of antiapoptotic B-cell lymphoma 2 (Bcl-2) and proapoptotic Bcl-2-associated X protein (Bax), were measured by ...

Subject: Sex Hormones

Studies from Martin-Luther-University Provide New Data on Lymphoma

2012 MAY 23 ... findings, "Histone deacetylase inhibition restores cisplatin sensitivity of Hodgkin's lymphoma cells," are discussed in a new report. "Increasing evidence suggest that ...

Subject: Lymphoma

Studies from University of Halle-Wittenberg Reveal New Findings on Lymphoma

2012 MAY 23 ... by histone deacetylases) play a major role in the pathogenesis of Hodgkin's lymphoma (HL). We treated HL cell lines with the histone deacetylase inhibitor vorinostat ...

Subject: Lymphoma

Study Data from Vita Salute University Update Knowledge of HIV/AIDS and Kaposi Sarcoma

2012 MAY 23 ... type showed higher survival rates during the post-HAART era in the case of non-Hodgkin lymphoma (10-year survival: 42.1% +/- 5.3% vs. 11.4% +/- 3.3%; log-rank test: p ...

Subject: HIV/AIDS and Kaposi Sarcoma

Study Results from Chase Farm Hospital Broaden Understanding of HIV/AIDS

2012 MAY 23 ... "Interim PET scans in HIV-negative patients with Hodgkin lymphoma has emerged as one of the most important prognostic tools. However, equivalent ...

Subject: HIV/AIDS

Study Results from University of Rochester Provide New Insights into Lymphoma

2012 MAY 23 ... mitochondrial proteins, we hypothesized that CDDO-induced protein aggregation and lymphoma apoptosis occur by inactivating this enzyme. Here, we show that CDDO and its ...

Subject: Lymphoma

University of Southampton Details Research in Follicular Lymphoma

2012 MAY 23 ... immune system: from pathogenesis to antibody therapy. 'Follicular lymphoma (FL) is a B-cell tumor arising in germinal centers and retaining features of its normal B-cell ... Fresh data on Follicular Lymphoma are presented in the report "Follicular lymphoma and the immune system: from ...

Subject: Follicular Lymphoma

Virginia Commonwealth University Details Research in Leukemia

2012 MAY 23 ... rather than ERBB2. In parallel, we noted in CNS tumor cells that knockdown of BCL-xL (B-cell lymphoma-extra large) and MCL-1 (myeloid cell leukemia-1) interacted in an additive fashion ...

Subject: Leukemia